These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 11123377

  • 1. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
    Thomas NJ, Carcillo JA, Herzer WA, Mi Z, Jackson EK.
    J Pharmacol Exp Ther; 2001 Jan; 296(1):168-74. PubMed ID: 11123377
    [Abstract] [Full Text] [Related]

  • 2. Treatment with the type IV phosphodiesterase inhibitor Ro 20-1724 protects renal and mesenteric blood flow in endotoxemic rats treated with norepinephrine.
    Carcillo JA, Herzer WA, Mi Z, Thomas NJ, Jackson EK.
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1197-204. PubMed ID: 8968341
    [Abstract] [Full Text] [Related]

  • 3. Lipopolysaccharide-induced acute renal failure in conscious rats: effects of specific phosphodiesterase type 3 and 4 inhibition.
    Jonassen TE, Graebe M, Promeneur D, Nielsen S, Christensen S, Olsen NV.
    J Pharmacol Exp Ther; 2002 Oct; 303(1):364-74. PubMed ID: 12235272
    [Abstract] [Full Text] [Related]

  • 4. Effects of rolipram and cilostamide on renal functions and cyclic AMP release in anesthetized dogs.
    Tanahashi M, Hara S, Yoshida M, Suzuki-Kusaba M, Hisa H, Satoh S.
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1533-8. PubMed ID: 10336549
    [Abstract] [Full Text] [Related]

  • 5. Reversal of acute tacrolimus-induced renal vasoconstriction by theophylline in rats.
    McLaughlin GE, Kashimawo LA, Steele BW, Kuluz JW.
    Pediatr Crit Care Med; 2003 Jul; 4(3):358-62. PubMed ID: 12831420
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effects of selective nitric oxide synthase blocker on survival, mesenteric blood flow and multiple organ failure induced by zymosan.
    Tanriverdi P, Yuksel BC, Rasa K, Guler G, Iskit AB, Guc MO, Korkmaz A.
    J Surg Res; 2005 Mar; 124(1):67-73. PubMed ID: 15734481
    [Abstract] [Full Text] [Related]

  • 9. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P, Volpin R, Piovan D, Bortoluzzi A, Craighero R, Bottaro S, Finucci GF, Casiglia E, Sticca A, De Toni R, Pavan L, Gatta A.
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [Abstract] [Full Text] [Related]

  • 10. Type IV phosphodiesterase inhibition improves cardiac contractility in endotoxemic rats.
    Thomas NJ, Carcillo JA, Herzer WA, Mi Z, Tofovic SP, Jackson EK.
    Eur J Pharmacol; 2003 Mar 28; 465(1-2):133-9. PubMed ID: 12650842
    [Abstract] [Full Text] [Related]

  • 11. An increased regional blood flow precedes mesenteric inflammation in rats treated by a phosphodiesterase 4 inhibitor.
    Korkmaz S, Maupoil V, Sobry C, Brunet C, Chevalier S, Freslon JL.
    Toxicol Sci; 2009 Jan 28; 107(1):298-305. PubMed ID: 18922941
    [Abstract] [Full Text] [Related]

  • 12. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS, Takakura AC, Menani JV, Colombari E.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):164-71. PubMed ID: 17382316
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effects of L-NG-nitroarginine in a zymosan-induced multiple organ dysfunction syndrome model.
    Ozel H, Yuksel BC, Berkem H, Avsar FM, Guler G, Iskit AB, Guc MO, Hengirmen S.
    Eur Surg Res; 2009 Jun 01; 43(2):211-8. PubMed ID: 19556797
    [Abstract] [Full Text] [Related]

  • 15. Aminoguanidine attenuates endotoxin-induced mesenteric vascular hyporeactivity.
    Kavuklu B, Iskit AB, Guc MO, Ilhan M, Sayek I.
    Br J Surg; 2000 Apr 01; 87(4):448-53. PubMed ID: 10759741
    [Abstract] [Full Text] [Related]

  • 16. Effect of the type IV phosphodiesterase inhibitor Ro 20-1724 on catecholamine-induced alterations in regional vascular resistance and regional blood flow.
    Thomas NJ, Herzer WA, Carcillo JA, Jackson EK.
    J Cardiovasc Pharmacol; 1998 Jun 01; 31(6):840-53. PubMed ID: 9641468
    [Abstract] [Full Text] [Related]

  • 17. Effects of sarafotoxin S6c on antidiuresis and norepinephrine overflow induced by stimulation of renal nerves in anesthetized dogs.
    Matsuo G, Matsumura Y, Tadano K, Morimoto S.
    J Pharmacol Exp Ther; 1997 Feb 01; 280(2):905-10. PubMed ID: 9023305
    [Abstract] [Full Text] [Related]

  • 18. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
    Tiwari S, Dong H, Kim EJ, Weintraub L, Epstein PM, Lerner A.
    Biochem Pharmacol; 2005 Feb 01; 69(3):473-83. PubMed ID: 15652238
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.
    Kalambokis G, Economou M, Fotopoulos A, Al Bokharhii J, Pappas C, Katsaraki A, Tsianos EV.
    Am J Gastroenterol; 2005 Apr 01; 100(4):879-85. PubMed ID: 15784036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.